» Articles » PMID: 38243240

Cell-cell Communication Characteristics in Breast Cancer Metastasis

Overview
Publisher Biomed Central
Date 2024 Jan 19
PMID 38243240
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer, a highly fatal disease due to its tendency to metastasize, is the most prevalent form of malignant tumors among women worldwide. Numerous studies indicate that breast cancer exhibits a unique predilection for metastasis to specific organs including the bone, liver, lung, and brain. However, different types of, The understanding of the heterogeneity of metastatic breast cancer has notably improved with the recent advances in high-throughput sequencing techniques. Focusing on the modification in the microenvironment of the metastatic organs and the crosstalk between tumor cells and in situ cells, noteworthy research points include the identification of two distinct modes of tumor growth in bone metastases, the influence of type II pneumocyte on lung metastases, the paradoxical role of Kupffer cells in liver metastases, and the breakthrough of the blood-brain barrier (BBB) breach in brain metastases. Overall, this review provides a comprehensive overview of the characteristics of breast cancer metastases, shedding light on the pivotal roles of immune and resident cells in the development of distinct metastatic foci.

Citing Articles

Cannabinoid Receptor Type 2 Agonist, GW405833, Reduced the Impacts of MDA-MB-231 Breast Cancer Cells on Bone Cells.

Inson I, Chutoe C, Kanjanapipak J, Lertsuwan K Cancer Med. 2025; 14(4):e70709.

PMID: 39980332 PMC: 11842928. DOI: 10.1002/cam4.70709.


Construction of a novel mitochondrial oxidative stress-related genes prognostic system and molecular subtype characterization for breast cancer.

Liu Y, Li Y, Zhu Y, Wang M, Luan Z Discov Oncol. 2024; 15(1):631.

PMID: 39514138 PMC: 11549074. DOI: 10.1007/s12672-024-01522-y.


Neutrophil-targeted liposomal platform: A shift in novel approach for early detection and treatment of cancer metastasis.

Li C, Zhang K, Cheng Z, Wang L, Li Z, Shen C Asian J Pharm Sci. 2024; 19(5):100949.

PMID: 39474126 PMC: 11513460. DOI: 10.1016/j.ajps.2024.100949.


The signature of extracellular vesicles in hypoxic breast cancer and their therapeutic engineering.

Zhu B, Xiang K, Li T, Li X, Shi F Cell Commun Signal. 2024; 22(1):512.

PMID: 39434182 PMC: 11492701. DOI: 10.1186/s12964-024-01870-w.


Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective.

Elaasser B, Arakil N, Mohammad K Int J Mol Sci. 2024; 25(5).

PMID: 38474093 PMC: 10932255. DOI: 10.3390/ijms25052846.

References
1.
El Rayes T, Catena R, Lee S, Stawowczyk M, Joshi N, Fischbach C . Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1. Proc Natl Acad Sci U S A. 2015; 112(52):16000-5. PMC: 4703007. DOI: 10.1073/pnas.1507294112. View

2.
Venetis K, Piciotti R, Sajjadi E, Invernizzi M, Morganti S, Criscitiello C . Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management. Cells. 2021; 10(6). PMC: 8229615. DOI: 10.3390/cells10061377. View

3.
Ni J, Ramkissoon S, Xie S, Goel S, Stover D, Guo H . Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases. Nat Med. 2016; 22(7):723-6. PMC: 4938731. DOI: 10.1038/nm.4120. View

4.
Malekan M, Nezamabadi S, Samami E, Mohebalizadeh M, Saghazadeh A, Rezaei N . BDNF and its signaling in cancer. J Cancer Res Clin Oncol. 2022; 149(6):2621-2636. DOI: 10.1007/s00432-022-04365-8. View

5.
Tan S, Krasnow M . Developmental origin of lung macrophage diversity. Development. 2016; 143(8):1318-27. PMC: 4852511. DOI: 10.1242/dev.129122. View